CHH
Choice Hotels International, Inc.
CHH trails on the overall score without a compensating advantage in the available component scores.
F
Ford Motor Company
F has the edge over CHH overall, supported by stronger modeled upside and lower modeled downside.
CHH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Weak |
CHH's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is weak.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
CHH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $73.78 | -38% |
| Forward | 16x | $118 | — |
| Fair | 21x | $95.93 | -19% |
| Current | 26x | $118 | — |
| Expensive | 35x | $155 | +31% |
Historical ranges are pointers, not guarantees.
CHH's PE is in its fair range at 26x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
CHH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CHH, but weaker profitability.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect F's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CHH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.52 | +68% |
| Q3 2026 | $4.48 | -45% |
| Q2 2026 | $7.06 | +9.1% |
| Q1 2026 | $7.40 | +13% |
| Q4 2025 | $7.90 | +27% |
| Q3 2025 | $8.11 | +55% |
| Q2 2025 | $6.47 | +34% |
| Q1 2025 | $6.52 | +40% |
| Q4 2024 | $6.20 | +22% |
CHH has the edge over F on earnings quality, reporting a profit while its opponent remains loss making.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
CHH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $458.3M | +2.5% |
| Q2 2026 | $440.8M | +3.4% |
| Q1 2026 | $340.6M | +2.3% |
| Q4 2025 | $390.2M | +0.1% |
| Q3 2025 | $447.3M | +4.5% |
| Q2 2025 | $426.4M | -2% |
| Q1 2025 | $332.9M | +0.3% |
| Q4 2024 | $389.8M | +8.8% |
CHH has the edge over F on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | -8.6 points |
| Q2 2026 | 24% | -5.6 points |
| Q1 2026 | 18% | -6.4 points |
| Q4 2025 | 26% | -4.6 points |
| Q3 2025 | 32% | -3.6 points |
| Q2 2025 | 29% | -1.3 points |
| Q1 2025 | 24% | +5.9 points |
| Q4 2024 | 31% | +20 points |
CHH has the edge over F on profitability, with a higher operating margin.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F's revenue grew through 2023 and has held roughly level since: $49.5B last quarter, down 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F's operating margin was 2.9% last quarter, about level with the same quarter a year ago.
CHH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44.3M | -9.7% |
| Q2 2026 | $80.1M | +22% |
| Q1 2026 | -$40M | -$25M |
| Q4 2025 | $64.1M | +12% |
| Q3 2025 | $49.1M | -70% |
| Q2 2025 | $65.4M | -8% |
| Q1 2025 | -$15M | +$16M |
| Q4 2024 | $57.4M | +296% |
CHH still generates free cash flow, though less than at its 2024 peak: $149M over the past year.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F has the edge over CHH on cash flow, with more consistent year-over-year improvement.
CHH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -317K shares |
| 1 year | -3% | -1.4M shares |
| 3 years | -11% | -5.4M shares |
| 5 years | -19% | -10.8M shares |
| Available history | -19% | -10.6M shares |
CHH has the edge over F on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $58.7M |
| Q2 2026 | $51M |
| Q1 2026 | $56.5M |
| Q4 2025 | $25.3M |
| Q3 2025 | $202,000 |
| Q2 2025 | $48.1M |
| Q1 2025 | $64.6M |
| Q4 2024 | $31.8M |
CHH spent $192M buying back its own shares over the past year, up 32% from the year before.
F Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.2% | +89M shares |
| 1 year | +0.7% | +28M shares |
| 3 years | +0.6% | +26M shares |
| 5 years | +1% | +40M shares |
| Available history | +1.8% | +72M shares |
F has 4.1B diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $311M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $150M |
F spent $311M buying back its own shares over the past year, up 107% from the year before.
CHH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.6x | High |
| Q2 2026 | 4.1x | High |
| Q1 2026 | 4.0x | Elevated |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 3.6x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.5x | Elevated |
| Q4 2024 | 3.4x | Elevated |
CHH's net debt is about 4.6 years of its operating earnings (EBITDA), up from 3.6 years a year ago.
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has the edge over CHH on leverage, with a lower net debt burden relative to earnings.
CHH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.3 | Neutral |
| Stochastic | 83.8 | Overbought |
CHH's weekly RSI is 62 (neutral) and its Stochastic is 84 (overbought).
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
CHH PE vs Consumer Cyclical Sector
| Metric | CHH | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 18x | 47% above |
| PE % | 65 | 47 | 18 pts above |
CHH is trading at 26x earnings, a 47% premium to the Consumer Cyclical sector's median of 18x.
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
CHH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $109.4 | 8.1% above |
| 20 week MA | $107.8 | 9.8% above |
| 50 week MA | $106.2 | 11% above |
| 100 week MA | $115.5 | 2.5% above |
| 200 week MA | $119.2 | 0.8% below |
CHH has the edge over F on trend strength, trading above more of its moving averages.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
CHH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $104.9 | $104.1 | -0.8% |
| 2021 | $104.1 | $152.7 | +47% |
| 2022 | $152.7 | $112.2 | -27% |
| 2023 | $112.2 | $113.3 | +1% |
| 2024 | $113.3 | $140.8 | +24% |
| 2025 | $140.8 | $96.0 | -32% |
| 2026 YTD | $96.0 | $118.3 | +23% |
CHH has the edge over F on returns for 2026, with the stronger performance.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F's yearly returns have swung widely, from +129% in 2021 to −44% in 2022. It's down 11% so far in 2026.